The Roche Venture Fund is a CHF 750 million evergreen corporate venture capital fund investing in innovative life science companies across therapeutics, diagnostics, and digital health.

Basel, Switzerland · 37+ investments · 41 portfolio companies

Seed
Early Stage
Growth
Biotech
Healthcare
Life Sciences
Diagnostics
Digital Health
Headquarters
Basel, Switzerland
Founded
2002
Website
roche.com
AUM
$750.0M
Portfolio Companies
41
Total Investments
37
Last Investment
Oct 2025
Geographic Focus
Global, Europe, United States

Investment Thesis

Supports the creation of commercially successful life science companies through strategic investments.

Roche is a Venture Capital firm based in Basel, Switzerland. It has made 37 investments, including Entrada Therapeutics, Viewics and NMD Pharma. Focus areas include Biotech and Healthcare.

Fund Family

Portfolio41

Co-investors24

Sign up to view co-investors

24 co-investors across 74 shared portfolio companies — who they back alongside, and how often they lead.

Venture Capital ×17 · Corporate VC ×5 · Hedge Fund ×1 · 50 shared rounds

Investment History

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

Roche on Indexed.vc
<a href="https://indexed.vc/investors/roche"><img src="https://indexed.vc/api/badge/investor/roche" alt="Roche on Indexed.vc" width="260" height="76" /></a>